Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 11;142(6):611-614.
doi: 10.1161/CIRCULATIONAHA.120.048925. Epub 2020 Jun 17.

Systemic Inflammatory Response Syndrome Is a Major Contributor to COVID-19-Associated Coagulopathy: Insights From a Prospective, Single-Center Cohort Study

Paul Masi  1 , Guillaume Hékimian  1 , Manon Lejeune  1 , Juliette Chommeloux  1 , Cyrielle Desnos  1 , Marc Pineton De Chambrun  1 , Isabelle Martin-Toutain  1 , Ania Nieszkowska  1 , Guillaume Lebreton  1 , Nicolas Bréchot  1 , Matthieu Schmidt  1 , Charles Edouard Luyt  1 , Alain Combes  1 , Corinne Frere  1
Affiliations

Systemic Inflammatory Response Syndrome Is a Major Contributor to COVID-19-Associated Coagulopathy: Insights From a Prospective, Single-Center Cohort Study

Paul Masi et al. Circulation. .
No abstract available

Keywords: COVID-19; respiratory distress syndrome, adult; systemic inflammatory response syndrome.

PubMed Disclaimer

References

    1. Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood 20201352033–2040doi: 10.1182/blood.2020006000 - PMC - PubMed
    1. Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, Merdji H, Clere-Jehl R, Schenck M, Fagot Gandet F, et al. ; CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis) High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intens Care Med 2020461089–1098doi: 10.1007/s00134-020-06062-x - PMC - PubMed
    1. Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F, Jeanpierre E, Rauch A, Labreuche J, Susen S; Lille ICU Haemostasis COVID-19 Group Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence. Circulation 2020142184–186doi: 10.1161/CIRCULATIONAHA.120.047430 - PubMed
    1. Joly BS, Siguret V, Veyradier A. Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19 [published online May 15, 2020]. Intens Care Med. doi: 10.1007/s00134-020-06088-1. https://link.springer.com/article/10.1007/s00134-020-06088-1. - DOI - PMC - PubMed
    1. Jackson SP, Darbousset R, Schoenwaelder SM. Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms. Blood 2019133906–918doi: 10.1182/blood-2018-11-882993 - PubMed

MeSH terms